Pharamocokinetics study of recombinant thrombomodulin in pediatric patients with hematological disease

Pharamocokinetics study of recombinant thrombomodulin in pediatric patients with hematological disease - PK study of recombinant thrombomodulin in pediatric patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007553

Enrollment

Registered

2012-04-01

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pediatric patients with hematological disease

Interventions

blood sampling

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with hematological and oncological disease who suffer from disseminated intravascular coagulation.

Exclusion criteria

Exclusion criteria: 1. Patients who are contraindicated from being used Recomodulin 2. severe renal insufficiency 3. Patients who are excluded from the study by physicians' decision

Design outcomes

Primary

Measure	Time frame
pharmacokinetics of recombinant thrombomodulin	—

Secondary

Measure	Time frame
recovery rate from disseminated intravascular coagulation, change in laboratory data including coagulation tests before and after administration of recombinant thrombomodulin	—

Countries

Japan

Contacts

Public ContactGoto, Hiroaki

Kanagawa Children's medical center hematology/reproduction medicine

hgotou@kcmc.jp045-711-2351

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026